Abstract:Abstract Background Due to the high prevalence and complex etiology, bovine mastitis (BM) is one of the most important diseases to compromise dairy cow health and milk quality. The shift in milk compositions has been widely investigated during mastitis, but recent studies suggested that gastrointestinal microorganism also has a crucial effect on the inflammation of other peripheral tissues and organs, including the mammary gland. However, research focused on the variation of rumen inner-environment during mastitis is still limited. Therefore, the ruminal microbial profiles, metabolites, and milk compositions in cows with different udder health conditions were compared in the present study. Furthermore, the correlations between udder health status and ruminal conditions were investigated. Based on the somatic cell counts (SCC), California mastitis test (CMT) parameters and clinical symptoms of mastitis, 60 lactating Holstein dairy cows with similar body conditions (excepted for the udder health condition) were randomly divided into 3 groups ( n = 20 per group) including the healthy (H) group, the subclinical mastitis (SM) group and the clinical mastitis (CM) group. Lactation performance and rumen fermentation parameters were recorded. And rumen microbiota and metabolites were also analyzed via 16S rRNA amplicon sequencing and untargeted metabolomics, respectively. Results As the degree of mastitis increased, rumen lactic acid (LA) ( P < 0.01), acetate, propionate, butyrate, valerate ( P < 0.001), and total volatile fatty acids (TVFAs) ( P < 0.01) concentrations were significantly decreased. In the rumen of CM cows, the significantly increased bacteria related to intestinal and oral inflammation, such as Lachnospiraceae (FDR-adjusted P = 0.039), Moraxella (FDR-adjusted P = 0.011) and Neisseriaceae (FDR-adjusted P = 0.036), etc., were accompanied by a significant increase in 12-oxo-20-dihydroxy-leukotriene B4 (FDR-adjusted P = 5.97 × 10 − 9 ) and 10beta-hydroxy-6beta-isobutyrylfuranoeremophilane (FDR-adjusted P = 3.88 × 10 − 10 ). Meanwhile, in the rumen of SM cows, the Ruminiclostridium_9 (FDR-adjusted P = 0.042) and Enterorhabdus (FDR-adjusted P = 0.043) were increased along with increasing methenamine (FDR-adjusted P = 6.95 × 10 − 6 ), 5-hydroxymethyl-2-furancarboxaldehyde (5-HMF) (FDR-adjusted P = 2.02 × 10 − 6 ) and 6-methoxymellein (FDR-adjusted P = 2.57 × 10 − 5 ). The short-chain fatty acids (SCFAs)-producing bacteria and probiotics in rumen, including Prevoterotoella_1 (FDR-adjusted P = 0.045) and Bifidobacterium (FDR-adjusted P = 0.035), etc., were significantly reduced, with decreasing 2-phenylbutyric acid (2-PBA) (FDR-adjusted P = 4.37 × 10 − 6 ). Conclusion The results indicated that there was a significant shift in the ruminal microflora and metabolites associated with inflammation and immune responses during CM. Moreover, in the rumen of cows affected by SM, the relative abundance of several opportunistic pathogens and the level of metabolites which could produce antibacterial compounds or had a competitive inhibitory effect were all increased.

Coupling 16S Rdna Sequencing and Untargeted Mass Spectrometry for Milk Microbial Composition and Metabolites from Dairy Cows with Clinical and Subclinical Mastitis.

The 16S rDNA high-throughput sequencing correlation analysis of milk and gut microbial communities in mastitis Holstein cows

Microbiome and metabolome analyses of milk and feces from dairy cows with healthy, subclinical, and clinical mastitis

A Study on Differential Biomarkers in the Milk of Holstein Cows with Different Somatic Cells Count Levels

Ultra-performance Liquid Chromatography-Quadrupole-time of Flight Mass Spectrometry MSE-based Untargeted Milk Metabolomics in Dairy Cows with Subclinical or Clinical Mastitis.

Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis

Discrepancies among Healthy, Subclinical Mastitic, and Clinical Mastitic Cows in Fecal Microbiome and Metabolome and Serum Metabolome.

Integrated analysis of transcriptome and milk metagenome in subclinical mastitic and healthy cows

Insights Into the Bovine Milk Microbiota in Dairy Farms With Different Incidence Rates of Subclinical Mastitis

Metabolomic Analysis of Multiple Biological Specimens (Feces, Serum, and Urine) by 1H-NMR Spectroscopy from Dairy Cows with Clinical Mastitis

PacBio Sequencing Revealed Variation in the Microbiota Diversity, Species Richness and Composition Between Milk Collected from Healthy and Mastitis Cows

Milk Metabolite Profiling of Dairy Cows As Influenced by Mastitis

Bacterial Community Profiling of Milk Samples As a Means to Understand Culture-Negative Bovine Clinical Mastitis.

Relationship Between Microflora Changes and Mammary Lipid Metabolism in Dairy Cows with Mastitis

Revealing Microbial Diversity in Buffalo Milk with High Somatic Cell Counts: Implications for Mastitis Diagnosis and Treatment.

Investigating the Reciprocal Interrelationships among the Ruminal Microbiota, Metabolome, and Mastitis in Early Lactating Holstein Dairy Cows

Integrative Analysis of miRNA and mRNA Expression Profiles in Mammary Glands of Holstein Cows Artificially Infected with Staphylococcus aureus

Matrine-chitosan hydrogels for treating subclinical bovine mastitis by intramammary infusion—effect on milk microbiome and metabolites

Differences in milk microbiota between healthy cows and cows with recurring mastitis

Preliminary Study on Gene Regulation and Its Pathways in Chinese Holstein Cows with Clinical Mastitis Caused by Staphylococcus Aureus

Transcriptomics and Itraq-Proteomics Analyses of Bovine Mammary Tissue with Streptococcus Agalactiae-Induced Mastitis.